Geraldine Dawson
Director, Duke Center for Autism & Brain Development
William Cleland Distinguished Professor
Overview
Geraldine Dawson is the William Cleland Distinguished Professor of Psychiatry and Behavioral Sciences at Duke University, where she also is Professor of Pediatrics and Psychology & Neuroscience. Dawson is the Director of the Duke Institute for Brain Sciences whose mission is to promote interdisciplinary brain science and translate discoveries into solutions for health and society. Dawson also is Director of the Duke Center for Autism and Brain Development, an NIH Autism Center of Excellence, which is an interdisciplinary research program and clinic, aimed to improve the lives of those with autism through research, education, clinical services, and policy. Dawson is Associate Director of the Marcus Center for Cellular Cures which aims to discover cellular treatments that can improve outcomes and quality of life for individuals with autism. Dawson received a Ph.D. in Developmental and Child Clinical Psychology from the University of Washington and completed a clinical internship at the UCLA Neuropsychiatric Institute.
Dawson previously served as President of the International Society for Autism Research and was appointed by the US Secretary of Health as a member of the NIH Interagency Autism Coordinating Committee (IACC) which develops the federal strategic plan for autism research, services, and policy. Dawson was Founding Director of the University of Washington (UW) Autism Center and the Duke Center for Autism and Brain Development, Dawson was awarded the American Psychological Association Distinguished Career Award (Div53); Association for Psychological Science Lifetime Achievement Award; Clarivate Top 1% Cited Researcher Across All Scientific Fields; NIH Top Research Advances of the Year Award (2007, 2008, 2009, 2010, 2012, 2013, 2015, 2016, 2017, 2018); Autism Society of America Award for Research Contributions; Autism Society Medical Professional of the Year; and Autism Society Award for Valuable Service. Dawson is a Fellow of the American Psychological Society and American Psychological Association, and is Associate Editor or on editorial boards of four scientific journals.
Elected. American Academy of Arts and Sciences. April 23, 2020
Distinguished Career Award. American Psychological Association. August 09, 2019
Selected Grants
Novel Approaches to Infant Screening for ASD in Pediatric Primary Care awarded by National Institutes of Health (Principal Investigator). 2019 to 2024
Scalable Computational Platform For Active Closed-Loop Behavioral Coding in Autism Spectrum Disorder awarded by National Institutes of Health (Co-Principal Investigator). 2019 to 2023
Duke CTSA (TL1) awarded by National Institutes of Health (Mentor). 2018 to 2023
Co-occurring ADHD in young children with ASD: Precursors, detection, neural signatures, and early treatment awarded by National Institutes of Health (Principal Investigator). 2017 to 2022
Digital Behavioral Outcome Measures for Autism awarded by (Co-Principal Investigator). 2019 to 2022
Marcus Foundation Phase II MSC ASD awarded by (Co-Principal Investigator). 2019 to 2022
Tailoring treatment targets for early autism intervention in Africa awarded by National Institutes of Health (Co Investigator). 2019 to 2021
Pilot Study to Improve Access to Early Intervention for Autism in Africa awarded by National Institutes of Health (Mentor). 2015 to 2021
Building a streamlined birth cohort to study autism risk factors and biomarkers awarded by Drexel University (Principal Investigator). 2020 to 2021
Duke Expanded Access Protocol Proposal for the Cord Blood Association Foundation awarded by (Principal Investigator). 2020
Pages
McPartland, J. C., et al. “Autism Spectrum Disorder.” Encyclopedia of Mental Health: Second Edition, 2016, pp. 124–30. Scopus, doi:10.1016/B978-0-12-397045-9.00230-5. Full Text
Filipek, P. A., et al. “The screening and diagnosis of autistic spectrum disorders.” The Science of Mental Health: Volume 2: Autism, 2013, pp. 11–56.
Dawson, G., and L. Sterling. “Autism Spectrum Disorders.” Encyclopedia of Infant and Early Childhood Development, vol. 1–3, 2008, pp. 137–43. Scopus, doi:10.1016/B978-012370877-9.00016-5. Full Text
Dawson, G., and K. Toth. “Autism Spectrum Disorders.” Developmental Psychopathology: Second Edition, vol. 3, 2006, pp. 317–57. Scopus, doi:10.1002/9780470939406.ch8. Full Text
Minshew, N. J., et al. “Neuropsychology and neurophysiology of autism spectrum disorders.” Understanding Autism: From Basic Neuroscience to Treatment, 2006, pp. 379–415.
Volkmar, Fred R., et al. “Duane F. Alexander, M.D.: August 11, 1940-February 16, 2020.” J Autism Dev Disord, vol. 50, no. 7, July 2020, pp. 2641–42. Pubmed, doi:10.1007/s10803-020-04534-z. Full Text
Sun, Jessica M., et al. “Infusion of human umbilical cord tissue mesenchymal stromal cells in children with autism spectrum disorder.” Stem Cells Transl Med, June 2020. Pubmed, doi:10.1002/sctm.19-0434. Full Text
Bangerter, Abigail, et al. “Clinical Validation of the Autism Behavior Inventory: Caregiver-Rated Assessment of Core and Associated Symptoms of Autism Spectrum Disorder.” J Autism Dev Disord, vol. 50, no. 6, June 2020, pp. 2090–101. Pubmed, doi:10.1007/s10803-019-03965-7. Full Text
Ness, Seth, et al. “Publisher Correction: ASPI: a public-private partnership to develop treatments for autism.” Nat Rev Drug Discov, vol. 19, no. 6, June 2020, p. 427. Pubmed, doi:10.1038/s41573-020-0069-5. Full Text
Major, Samantha, et al. “Impact of a digital Modified Checklist for Autism in Toddlers-Revised on likelihood and age of autism diagnosis and referral for developmental evaluation.” Autism, May 2020, p. 1362361320916656. Pubmed, doi:10.1177/1362361320916656. Full Text
Dawson, Geraldine, et al. “A Phase II Randomized Clinical Trial of the Safety and Efficacy of Intravenous Umbilical Cord Blood Infusion for Treatment of Children with Autism Spectrum Disorder.” J Pediatr, May 2020. Pubmed, doi:10.1016/j.jpeds.2020.03.011. Full Text
Bangerter, Abigail, et al. “Automated recognition of spontaneous facial expression in individuals with autism spectrum disorder: parsing response variability.” Mol Autism, vol. 11, no. 1, May 2020, p. 31. Pubmed, doi:10.1186/s13229-020-00327-4. Full Text
Ness, Seth, et al. “ASPI: a public-private partnership to develop treatments for autism.” Nat Rev Drug Discov, vol. 19, no. 4, Apr. 2020, pp. 219–20. Pubmed, doi:10.1038/d41573-020-00012-4. Full Text
Tenenbaum, Elena J., et al. “A Six-Minute Measure of Vocalizations in Toddlers with Autism Spectrum Disorder.” Autism Res, Mar. 2020. Pubmed, doi:10.1002/aur.2293. Full Text Open Access Copy
MacDuffie, Katherine E., et al. “Sleep Problems and Trajectories of Restricted and Repetitive Behaviors in Children with Neurodevelopmental Disabilities.” J Autism Dev Disord, Mar. 2020. Pubmed, doi:10.1007/s10803-020-04438-y. Full Text
Pages
Li, Y., et al. “On target shift in adversarial domain adaptation.” Aistats 2019 22nd International Conference on Artificial Intelligence and Statistics, 2020.
Carpenter, Kimberly L. H., et al. “1.14 GRAPH CURVATURE AS A METHOD FOR DISCERNING ROBUSTNESS IN BRAIN NETWORKS IN ASD.” Journal of the American Academy of Child & Adolescent Psychiatry, vol. 58, no. 10, Elsevier BV, 2019, pp. S151–S151. Crossref, doi:10.1016/j.jaac.2019.08.036. Full Text
Carpenter, Kimberly L. H., et al. “RELATIONSHIP BETWEEN SENSORY PROCESSING DIFFERENCES AND CLINICAL FEATURES OF CHILDREN WITH ASD.” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 58, no. 10, ELSEVIER SCIENCE INC, 2019, pp. S151–S151. Wos, doi:10.1016/jaac.2019.08.037. Full Text
Naples, Adam, et al. “EEG AND PUPILLARY RESPONSE IN CHILDREN WITH AUTISM: RESULTS FROM THE AUTISM BIOMARKERS CONSORTIUM FOR CLINICAL TRIALS INTERIM ANALYSIS.” Psychophysiology, vol. 56, WILEY, 2019, pp. S20–S20.
Ressler, B., et al. “Meeting the demands of msc production for clinical studies.” Cytotherapy, vol. 21, no. 5, Elsevier BV, 2019, pp. S81–82. Crossref, doi:10.1016/j.jcyt.2019.03.496. Full Text
Kurtzberg, J., et al. “MANUFACTURING OF ALLOGENEIC HUMAN CORD TISSUE MESENCHYMAL STROMAL CELLS: INITIAL RESULTS OF A PHASE I CLINICAL TRIAL IN CHILDREN WITH AUTISM SPECTRUM DISORDER.” Cytotherapy, vol. 20, no. 5, ELSEVIER SCI LTD, 2018, pp. S44–S44.
Li, Y., et al. “Extracting relationships by multi-domain matching.” Advances in Neural Information Processing Systems, vol. 2018-December, 2018, pp. 6798–809.
Carpenter, Kimberly, et al. “Phase I Open Label Trial of Autologous Cord Blood for Treatment of Autism: Correlations Between Behavioral Improvement and Increased White Matter Connectivity in Children With Autism.” Neuropsychopharmacology, vol. 42, NATURE PUBLISHING GROUP, 2017, pp. S495–96.
Pandina, G., et al. “Prospective, observational cohort study of JAKE (TM), an autism knowledge.” European Neuropsychopharmacology, vol. 27, ELSEVIER SCIENCE BV, 2017, pp. S1118–S1118.
Li, Y., et al. “Targeting EEG/LFP synchrony with neural nets.” Advances in Neural Information Processing Systems, vol. 2017-December, 2017, pp. 4621–31.